Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 3/20 | 0.37 |
| ▸ | MMP9 | P14780 | 3/20 | 0.37 |
| ▸ | MMP13 | P45452 | 3/20 | 0.37 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.37 |
| ▸ | CCR2 | P41597 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.31 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10655712 | 0.79 | CYP4F2 (0.46) | MAPK1L3MBTL1ALDH1A1MEN1TSHR | |
| SCHEMBL10881164 | 0.78 | MAPK1 (0.38) | MAPK1MMP1MMP9MMP13ADAM17 | |
| SCHEMBL16375064 | 0.77 | — | — | |
| SCHEMBL16375065 | 0.77 | — | — | |
| SCHEMBL2440426 | 0.77 | MAPK1 (0.39) | MAPK1CCR2L3MBTL1ALDH1A1MEN1 | |
| SCHEMBL365038 | 0.77 | DGAT1 (0.38) | DGAT1TSHR | |
| SCHEMBL17106359 | 0.77 | MAPK1 (0.41) | MAPK1MMP1MMP9MMP13ADAM17 | |
| SCHEMBL11743781 | 0.76 | MAPK1 (0.37) | MAPK1MMP1MMP9MMP13ADAM17 | |
| SCHEMBL631049 | 0.76 | CYP2C19 (0.38) | MMP1MMP9MMP13CCR2DGAT1 | |
| SCHEMBL1114811 | 0.75 | MAPK1 (0.40) | MAPK1CCR2L3MBTL1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122847-A1 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2017-02-01 | — | — | EP | claimed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | claimed |
| WO-2015148743-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | claimed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | claimed |
| EP-2279741-A2 | Caprolactams and their use as anti-inflammatory agents | Cambridge Enterprise Ltd. (GB) | 2011-02-02 | — | — | EP | claimed |
| US-20080227724-A1 | 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2008-09-18 | — | — | US | claimed |
| EP-1691814-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-08-23 | — | — | EP | claimed |
| WO-2005053702-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2005-06-16 | — | — | WO | claimed |
| EP-3521409-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2024-08-14 | — | — | EP | disclosed |
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| EP-0058632-B1 | (13E)-(8R,11R,12R)-11,15-DIHYDROXY-16,19-DIMETHYL-9-OXO-13,18-PROSTADIENOIC ACIDS AND THEIR SALTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-04-11 | — | — | EP | disclosed |
| US-4359467-A | Prostanoic acid derivatives and their preparation | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-11-16 | — | — | US | disclosed |
| EP-0059158-A2 | Aza prostacyclins, their preparation and therapeutic applications | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-09-01 | — | — | EP | disclosed |
| EP-0058632-A1 | (13E)-(8R,11R,12R)-11,15-dihydroxy-16,19-dimethyl-9-oxo-13,18-prostadienoic acids and their salts, their preparation and pharmaceutical compositions | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-08-25 | — | — | EP | disclosed |
| US-4284646-A | Prostanoic acid derivatives and their preparation | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-08-18 | — | — | US | disclosed |
| US-4220798-A | 19-Methyl-9-keto-15-hydroxy-prost-18-enoic acid derivatives and process of their preparation | SCOLASTICO CAROL (IT) | 1980-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227724-A1 | 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents | SMURF1, SMURF2, PSEN1 | MAPK1 3301/4885MMP1 1420/4885MMP9 1229/4885 |
| US-20160289593-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MAPK1 4423/4885MMP1 2221/4885MMP9 2905/4885 |
| US-20150275132-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MAPK1 4423/4885MMP1 2221/4885MMP9 2905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.